rediff.com
e.g. Tata motors, Reliance MF, 500570
POLY MEDICURE LTD. - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
Download announcement < Back
22 Jul 2024
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 22nd July, 2024 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, approved the following businesses: a) Unaudited Financial Results (Consolidate &amp; Standalone) for the first quarter ended on 30th June 2024. b) To Re-appoint and Ratification of Remuneration of M/s. Jai Prakash &amp; Company, Cost Accountants as Cost Auditors of the Company for the Financial Year 2024-25, subject to the approval of the shareholders in the forthcoming Annual General Meeting. c) To appoint Mr. Vimal Bhandari (DIN 0001318), as Non-Executive and Independent Director on the Board of the Company, subject to shareholder approval in upcoming Annual general meeting.
View all announcements for POLY MEDICURE LTD. Source: BSE India